Navigation Links
Overtime Work Tied to Anxiety, Depression
Date:6/19/2008

Rates were higher among less-skilled and those with lower incomes, study finds

THURSDAY, June 19 (HealthDay News) -- Working overtime puts you at a higher risk for developing anxiety and depression, a new study suggests.

Men who worked 40 hours a week or less had a 9 percent "possible" depression score on standard screening questionnaires, while 12.5 percent of their counterparts who worked overtime showed signs of depression and anxiety. For women, the possible depression rate increased from 7 percent to 11 percent.

The results, published in the June issue of the Journal of Occupational and Environmental Medicine, also show anxiety and depression rates were higher among less-skilled workers and those with lower incomes. The study looked at 1,350 overtime workers and 9,000 with normal work hours in Norway.

Men who worked the most overtime -- nine to 60 hours a week -- showed the greatest link to anxiety and depression. These men tended to have lower work skills and education levels than others and have jobs involving heavy manual labor and shift work. While these men were at highest risk, even moderate overtime work appeared to bump up the risk of "mental distress," the authors noted.

What causes working long hours to increase anxiety and depression was not explored in the study.

More information

The American Psychological Association has more about work stress.



-- Kevin McKeever



SOURCE: American College of Occupational and Environmental Medicine, news release, June 15, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Anxiety, mood disorders put cancer patients at risk for PTSD
2. Social Problems in Youth Contribute to Anxiety, Depression
3. Walk away menopausal anxiety, stress and depression
4. Diabetes and Depression Go Hand-in-Hand
5. Mayo Clinic study reveals rural, unmarried women at higher risk for depression
6. WellPoint Launches and Expands Maternity Depression Program
7. A call for standardized measurement of outcomes in depression treatment
8. Inflammation, depression and antidepressant response: Common mechanisms
9. Buyers Health Care Action Group Pilots New Bridges to Excellence Program for Depression
10. Antidepressants May Prevent Depression After Stroke
11. Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as ... helps transform the HCC Risk Adjustment process from a typical fragmented process ...
(Date:2/22/2017)... ... February 22, 2017 , ... Doctors on Liens is continuing its steady ... Steven H. Rauchman, practicing at North Valley Eye Medical Group in Mission Hills ... liability and other personal injury cases. These injuries have a major impact on ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Using the ... leads utilizing a simple online checklist. Over a period of just 24 months, thousands ... assistance of an online checklist called T.A.D. , “The internet is not getting quieter. ...
(Date:2/22/2017)... ... February 22, 2017 , ... The Centers for ... help small practices in Delaware, New Jersey, Pennsylvania and West Virginia prepare for ... and CHIP Reauthorization Act of 2015 (MACRA). , This technical assistance, authorized ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , February 23, 2017 ... market: the Berlin office was ... Magdalena Kritikos . The portfolio includes Entocort ® ... for the treatment of ulcerative colitis, and VistaPrep ® ... solutions, the Swiss specialty pharmaceutical company focused on the ...
(Date:2/23/2017)... 2017 MabVax Therapeutics Holdings, Inc ... company, announces that it has received notice from ... the initiation a Phase I clinical trial with ... MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel ... initiate the phase I clinical trial in patients ...
(Date:2/23/2017)... 23, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ... oncology and dermatology biopharmaceutical company, today announced that it ... Rodrigues as special advisers to the Company,s Board ... the board on financial and corporate strategy. ... commitment of up to $2.5 million from Eric ...
Breaking Medicine Technology: